Design of a Randomized Controlled Trial for Ebola Virus Disease Medical Countermeasures: PREVAIL II, the Ebola MCM Study

Background. Unique challenges posed by emerging infectious diseases often expose inadequacies in the conventional phased investigational therapeutic development paradigm. The recent Ebola outbreak in West Africa presents a critical case-study highlighting barriers to faster development. During the o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Infect Dis
Main Authors: Dodd, Lori E., Proschan, Michael A., Neuhaus, Jacqueline, Koopmeiners, Joseph S., Neaton, James, Beigel, John D., Barrett, Kevin, Lane, Henry Clifford, Davey, Richard T.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2016
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4878725/
https://ncbi.nlm.nih.gov/pubmed/26908739
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiw061
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados